Gelatin-encapsulated iron oxide nanoparticles for platinum (IV) prodrug delivery, enzyme-stimulated release and MRI

Biomaterials

Volumn 35, Issue 24, 2014, Pages 6359-6368

  Cheng, Ziyong ^a   Dai, Yunlu ^b   Kang, Xiaojiao ^b   Li, Chunxia ^a   Huang, Shanshan ^a   Lian, Hongzhou ^a   Hou, Zhiyao ^a   Ma, Pingan ^a   Lin, Jun ^a  

^a CHANGCHUN INSTITUTE OF APPLIED CHEMISTRY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Fluorescence quenching; Gelatin encapsulation; Iron oxide; Magnetic resonance imaging; Platinum (IV) prodrug

Indexed keywords

DISEASE CONTROL; DRUG DELIVERY; ENERGY TRANSFER; ENZYMES; FLUORESCENCE; HYDROPHOBICITY; IRON OXIDES; MAGNETIC RESONANCE IMAGING; METAL NANOPARTICLES;

FLUORESCEIN ISOTHIOCYANATE; FLUORESCENCE QUENCHING; FLUORESCENCE RECOVERY; IRON OXIDE NANOPARTICLE; IRON OXIDE NANOPARTICLES (IONPS); MAGNETIC RESONANCE IMAGES (MRI); PRODRUGS; RESONANCE ENERGY TRANSFER;

PLATINUM;

FERRIC ION; FERRIC OXIDE; FLUORESCEIN ISOTHIOCYANATE; GELATIN; NANOPARTICLE; PANCREATIN; PLATINUM; PRODRUG;

ANIMAL; CELL SURVIVAL; CHEMICAL PHENOMENA; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG EFFECTS; DRUG SCREENING; HUMAN; INFRARED SPECTROSCOPY; MCF 7 CELL LINE; METABOLISM; MOUSE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; SYNTHESIS; THERMOGRAVIMETRY; TISSUE DISTRIBUTION; ULTRASTRUCTURE; ULTRAVIOLET SPECTROPHOTOMETRY; X RAY DIFFRACTION; X RAY PHOTOELECTRON SPECTROSCOPY;

ANIMALS; CELL SURVIVAL; DRUG DELIVERY SYSTEMS; FERRIC COMPOUNDS; FLUORESCEIN-5-ISOTHIOCYANATE; GELATIN; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MAGNETIC RESONANCE IMAGING; MCF-7 CELLS; MICE; NANOPARTICLES; PANCREATIN; PARTICLE SIZE; PHOTOELECTRON SPECTROSCOPY; PLATINUM; PRODRUGS; SPECTROPHOTOMETRY, ULTRAVIOLET; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; THERMOGRAVIMETRY; TISSUE DISTRIBUTION; X-RAY DIFFRACTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84901454698     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.04.029     Document Type: Article

References (64)

1. Cheon J., Lee J.H. Synergistically integrated nanoparticles as multimodal probes for nanobiotechnology. Acc Chem Res 2008, 41:1630-1640.
2. Liu Z., Peng R. Inorganic nanomaterials for tumor angiogenesis imaging. Eur J Nucl Med Mol Imaging 2010, 37:S147-S163.
3. Tu D.T., Liu Y.S., Zhu H.M., Chen X.Y. Optical/magnetic multimodal bioprobes based on lanthanide-doped inorganic nanocrystals. Chem Eur J 2013, 19:5516-5527.
4. Maeda H., Wu J., Sawa T., Matsumura Y., Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. JControl Release 2000, 65:271-284.
5. Brigger I., Dubernet C., Couvreur P. Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev 2012, 64:24-36.
6. Chen Y., Chen H.R., Shi J.L. Invivo bio-safety evaluations and diagnostic/therapeutic applications of chemically designed mesoporous silica nanoparticles. Adv Mater 2013, 25:3144-3176.
7. Lewinski N., Colvin V., Drezek R. Cytotoxicity of nanoparticles. Small 2008, 4:26-49.
8. Li Y.F., Chen C.Y. Fate and toxicity of metallic and metal-containing nanoparticles for biomedical applications. Small 2011, 7:2965-2980.
9. Li M., Al-Jamal K.T., Kostarelos K., Reineke J. Physiologically based pharmacokinetic modeling of nanoparticles. ACS Nano 2010, 4:6303-6317.
10. Hao R., Xing R.J., Xu Z.C., Hou Y.L., Gao S., Sun S.H. Synthesis, functionalization, and biomedical applications of multifunctional magnetic nanoparticles. Adv Mater 2010, 22:2729-2742.
11. Xie J., Liu G., Eden H.S., Al H., Chen X.Y. Surface-engineered magnetic nanoparticle platforms for cancer imaging and therapy. Acc Chem Res 2011, 44:883-892.
12. Kim J., Lee J.E., Lee S.H., Yu J.H., Lee J.H., Park T.G., et al. Designed fabrication of a multifunctional polymer nanomedical platform for simultaneous cancer-targeted imaging and magnetically guided drug delivery. Adv Mater 2008, 20:478-483.
13. Ho D., Sun X.L., Sun S.H. Monodisperse magnetic nanoparticles for theranostic applications. Acc Chem Res 2011, 44:875-882.
14. 4 core at hybrid at Au shell nanocomposite for bimodal imaging and photothermal therapy. Adv Mater 2011, 23:5392-5397.
15. Cheng L., Wang C., Ma X.X., Wang Q.L., Cheng Y., Wang H., et al. Multifunctional upconversion nanoparticles for dual-modal imaging guided stem cell therapy under remote magnetic control. Adv Funct Mater 2013, 23:272-280.
16. Qi H., Zhu Y.H., Xu H.B., Yang X.L. Magnetic iron oxide nanoparticle-based theranostic nanomedicine. Prog Chem 2013, 25:611-619.
17. Wang Y.X.J., Hussain S.M., Krestin G.P. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur Radiol 2001, 11:2319-2331.
18. Qiao R.R., Yang C.H., Gao M.Y. Superparamagnetic iron oxide nanoparticles: from preparations to invivo MRI applications. JMater Chem 2009, 19:6274-6293.
19. Thomas L.A., Dekker L., Kallumadil M., Southern P., Wilson M., Nair S.P., et al. Carboxylic acid-stabilised iron oxide nanoparticles for use in magnetic hyperthermia. JMater Chem 2009, 19:6529-6535.
20. Jeun M., Bae S., Tomitaka A., Takemura Y., Park K.H., Paek S.H., et al. Effects of particle dipole interaction on the ac magnetically induced heating characteristics of ferrite nanoparticles for hyperthermia. Appl Phys Lett 2009, 95:082501.
21. 4 nanoparticles/pEgr1-HSV-TK/GCV associated with radiation and magnet-induced heating on hepatoma. Nanoscale 2013, 5:991-1000.
22. 4 particles in AC magnetic field. JMagn Magn Mater 2004, 268:33-39.
23. Shi D.L. Integrated multifunctional nanosystems for medical diagnosis and treatment. Adv Funct Mater 2009, 19:3356-3373.
24. Fan W.P., Shen B., Bu W.B., Chen F., Zhao K.L., Zhang S.J., et al. Rattle-structured multifunctional nanotheranostics for synergetic chemo-/radiotherapy and simultaneous magnetic/luminescent dual-mode imaging. JAm Chem Soc 2013, 135:6494-6503.
25. Chen Y., Yin Q., Ji X.F., Zhang S.J., Chen H.R., Zheng Y.Y., et al. Manganese oxide-based multifunctionalized mesoporous silica nanoparticles for pH-responsive MRI, ultrasonography and circumvention of MDR in cancer cells. Biomaterials 2012, 33:7126-7137.
26. Cheng L., Yang K., Li Y., Zeng X., Shao M., Lee S.T., et al. Multifunctional nanoparticles for upconversion luminescence/MR multimodal imaging and magnetically targeted photothermal therapy. Biomaterials 2012, 33:2215-2222.
27. Lee J.H., Huh Y.M., Jun Y., Seo J., Jang J., Song H.T., et al. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nat Med 2007, 13:95-99.
28. Park J., An K.J., Hwang Y.S., Park J.G., Noh H.J., Kim J.Y., et al. Ultra-large-scale syntheses of monodisperse nanocrystals. Nat Mater 2004, 3:891-895.
29. Sun S., Zeng H. Size-controlled synthesis of magnetite nanoparticles. JAm Chem Soc 2002, 124:8204-8205.
30. 4 nanoparticle aggregates as color reagents. Anal Chem 2011, 83:6778-6784.
31. Huh Y.M., Jun Y.W., Song H.T., Kim S., Choi J.S., Lee J.H., et al. Invivo magnetic resonance detection of cancer by using multifunctional magnetic nanocrystals. JAm Chem Soc 2005, 127:12387-12391.
32. 4 nanoparticles and their specific targeting to integrin alpha(v)beta3-rich tumor cells. JAm Chem Soc 2008, 130:7542-7543.
33. Piao Y., Park Y.I., Lee N., Yoo B., Kim B.H., Choi S.H., et al. Transformation of hydrophobic iron oxide nanoparticles to hydrophilic and biocompatible maghemite nanocrystals for use as highly efficient MRI contrast agent. JMater Chem 2011, 21:11472-11477.
34. Pellegrino T., Manna L., Kudera S., Liedl T., Koktysh D., Rogach A.L., et al. Hydrophobic nanocrystals coated with an amphiphilic polymer shell: a general route to water soluble nanocrystals. Nano Lett 2004, 4:703-707.
35. Yu W.W., Chang E., Sayes C.M., Drezek R., Colvin V.L. Aqueous dispersion of monodisperse magnetic iron oxide nanocrystals through phase transfer. Nanotechnology 2006, 17:4483-4487.
36. Wang C., Cheng L.A., Liu Z. Drug delivery with upconversion nanoparticles for multi-functional targeted cancer cell imaging and therapy. Biomaterials 2011, 32:1110-1120.
37. Zhao Z.H., Zhou Z.J., Bao J.F., Wang Z.Y., Hu J., Chi X.Q., et al. Octapod iron oxide nanoparticles as high-performance T-2 contrast agents for magnetic resonance imaging. Nat Comm 2013, 4:2266.
38. (2) at PMMA core-shell-shell magnetic microspheres for highly efficient enrichment of peptides and proteins for MALDI-ToF MS analysis. Angew Chem Inter Ed 2010, 49:607-611.
39. Kim J., Kim H.S., Lee N., Kim T., Kim H., Yu T., et al. Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescence imaging and for drug delivery. Angew Chem Inter Ed 2008, 47:8438-8441.
40. Young S., Wong M., Tabata Y., Mikos A.G. Gelatin as a delivery vehicle for the controlled release of bioactive molecules. JControl Release 2005, 109:256-274.
41. Zheng W., Zheng Y.F. Gelatin-functionalized carbon nanotubes for the bioelectrochemistry of hemoglobin. Electrochem Comm 2007, 9:1619-1623.
42. Liu K.P., Zhang J.J., Cheng F.F., Zheng T.T., Wang C.M., Zhu J.J. Green and facile synthesis of highly biocompatible graphene nanosheets and its application for cellular imaging and drug delivery. JMater Chem 2011, 21:12034-12040.
43. Ge Y., Wang J.L., Shi Z.X., Yin J. Gelatin-assisted fabrication of water-dispersible graphene and its inorganic analogues. Gelatin-assisted fabrication of water-dispersible graphene and its inorganic analogues. JMater Chem 2012, 22:17619-17624.
44. Mozafari M., Moztarzadeh F. Controllable synthesis, characterization and optical properties of colloidal PbS/gelatin core-shell nanocrystals. JColloid Interface Sci 2010, 351:442-448.
45. Wang Y.Q., Chen H.Y., Ye C., Hu Y.Z. Synthesis and characterization of CdTe quantum dots embedded gelatin nanoparticles via a two-step desolvation method. Mater Lett 2008, 62:3382-3384.
46. Kelland L. The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer 2007, 7:573-584.
47. Sastry J., Kellie S.J. Severe neurotoxicity, ototoxicity and nephrotoxicity following high-dose cisplatin and amifostine. Pediatr Hematol Oncol 2005, 22:441-445.
48. Hall M.D., Okabe M., Shen D.W., Liang X.J., Gottesman M.M. The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy. Annu Rev Pharmacol Toxicol 2008, 48:495-535.
49. Rieter W.J., Pott K.M., Taylor K.M.L., Lin W. Nanoscale coordination polymers for platinum-based anticancer drug delivery. JAm Chem Soc 2008, 130:11584-11585.
50. Dhar S., Kolishetti N., Lippard S.J., Farokhzad O.C. Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy invivo. Proc Natl Acad Sci U S A 2011, 108:1850-1855.
51. Yang J., Liu W.W., Sui M.H., Tang J.B., Shen Y.Q. Platinum (IV)-coordinate polymers as intracellular reduction-responsive backbone-type conjugates for cancer drug delivery. Biomaterials 2011, 32:9136-9143.
52. Dhar S., Daniel W.L., Giljohann D.A., Mirkin C.A., Lippard S.J. Polyvalent oligonucleotide gold nanoparticle conjugates as delivery vehicles for platinum(IV) warheads. JAm Chem Soc 2009, 131:14652-14653.
53. 3+ nanoparticles for targeted drug delivery and up-conversion cell imaging. Adv Healthc Mater 2013, 2:562-567.
54. Xing R.M., Wang X.Y., Zhang C.L., Wang J.Z., Zhang Y.M., Song Y., et al. Paramagnetic magnetite nanocrystal clusters as potential magnetic carriers for the delivery of platinum anticancer drugs. JMater Chem 2011, 21:11142-11149.
55. Koula V., Mohameda R., Kuckling D., Adler H.J.P., Choudhary V. Interpenetrating polymer network (IPN) nanogels based on gelatin and poly(acrylic acid) by inverse miniemulsion technique: synthesis and characterization. Colloids Surf B Biointerfaces 2011, 83:204-213.
56. Mane G.P., Talapaneni S.N., Anand C., Varghese S., Iwai H., Ji Q., et al. Preparation of highly ordered nitrogen-containing mesoporous carbon from a gelatin biomolecule and its excellent sensing of acetic acid. Adv Funct Mater 2012, 22:3596-3604.
57. Xiao H., Qi R., Liu S., Hu X., Duan T., Zheng Y., et al. Biodegradable polymer-cisplatin(IV) conjugate as a pro-drug of cisplatin(II). Biomaterials 2011, 32:7732-7739.
58. Hall M.D., Amjadi S., Zhang M., Beale P.J., Hambley T.W. The mechanism of action of platinum(IV) complexes in ovarian cancer cell lines. JInorg Biochem 2004, 98:1614-1624.
59. Chen N.T., Cheng S.H., Liu C.P., Souris J.S., Chen C.T., Mou C.Y., et al. Recent advances in nanoparticle-based Förster resonance energy transfer for biosensing, molecular imaging and drug release profiling. Int J Mol Sci 2012, 13:16598-16623.
60. Zhong W. Nanomaterials in fluorescence-based biosensing. Anal Bioanal Chem 2009, 394:47-59.
61. Cha E.J., Jang E.S., Sun I.C., Lee I.J., Ko J.H., Kim Y.I., et al. Development of MRI/NIRF 'activatable' multimodal imaging probe based on iron oxide nanoparticles. JControl Release 2011, 155:152-158.
62. Ge Y.Q., Zhang Y., He S.Y., Nie F., Teng G.J., Gu N. Fluorescence modified chitosan-coated magnetic nanoparticles for high-efficient cellular imaging. Nanoscale Res Lett 2009, 4:287-295.
63. Moore M.N. Do nanoparticles present ecotoxicological risks for the health of the aquatic environment. Environ Int 2006, 32:967-976.
64. Lee P.W., Hsu S.H., Wang J.J., Tsai J.S., Lin K.J., Wey S.P., et al. The characteristics, biodistribution, magnetic resonance imaging and biodegradability of superparamagnetic core-shell nanoparticles. Biomaterials 2010, 31:1316-1324.